Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT03762161 2022-03-10

A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms